Certified Smoking Cessation Units in Spain: High Potential for Detection of Undiagnosed Chronic Obstructive Pulmonary Disease and Profile of Newly Diagnosed Cases

References

• INE. Cifras de Población 1-1-2017 y Estadística Migraciones 2016 (Provisionales) (2/16) Evolución Del Crecimiento Anual de La Población de España (2012–2016). Porcentajes; 2017 [Population figures 1-1-2017 and (interim) migration statistics (2/16) Course of Annual Growth of Population in Spain (2012-2016). Percent values, 2017]. Available from: http://www.ine.es/prensa/cp_2017_p.pdf. Accessed January 26, 2021.
   Google Scholar
• Ministerio de Sanidad de España. Encuesta sobre alcohol y drogas en España (EDADES), 1995–2017; Published 2017 [Survey on alcohol and drugs in Spain (EDADES), 1995-2017]. Available from: https://pnsd.sanidad.gob.es/profesionales/sistemasInformacion/sistemaInformacion/pdf/EDADES_2017_Informe.pdf. Accessed September 9, 2020.
   Google Scholar
• Pérez-Ríos M, Schiaffino A, Montes A, et al. Smoking-attributable mortality in Spain in 2016. Arch Bronconeumol. 2020;56:9. doi:10.1016/j.arbres.2019.11.021
   Web of Science ®Google Scholar
• Jiménez-Ruiz CA, Solano Reina S, Barrueco Ferrero M, et al. Recomendaciones para la organización y funcionamiento de las unidades especializadas en tabaquismo [Recommendations for organization and operation of specialized smoking units]. Arch Bronconeumol. 2001;37(9):382–387. doi:10.1016/S0300-2896(01)78819-9
   PubMedGoogle Scholar
• Jiménez Ruiz CA, Manzano JR. La acreditación de las Unidades Especializadas en Tabaquismo [Accreditation of Specialized Smoking Units]. Arch Bronconeumol. 2020;56(9):59–60. doi:10.1016/j.arbres.2019.11.021
   PubMedGoogle Scholar
• SEPAR. Guía SEPAR para la actualización de unidades especializadas en Tabaquismo [SEPAR Guidelines for updating specialized smoking units]. Available from: https://issuu.com/separ/docs/guia_separ_acreditacion_unidades_de_tabaquismo. Accessed August 21, 2020.
   Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
   PubMed Web of Science ®Google Scholar
• World Health Organization. World health statistics 2008; 2008. Available from: https://www.who.int/whosis/whostat/EN_WHS08_Full.pdf?ua=1. Accessed August 22, 2020.
   Google Scholar
• Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148(4):971–985. doi:10.1378/chest.14-2535
   PubMed Web of Science ®Google Scholar
• Soriano JB, Miravitlles M, Borderías L, et al. Diferencias geográficas en la prevalencia de EPOC en España: relación con hábito tabáquico, tasas de mortalidad y otros determinantes [Geographical differences in the prevalence of COPD in Spain: its relationship with smoking habit, mortality rates and other determinants]. Arch Bronconeumol. 2010;46(10):522–530. doi:10.1016/j.arbres.2010.06.008
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, Fabricius P. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935–939. doi:10.1136/thx.2006.062802
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Spanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbr.2017.03.017
   PubMed Web of Science ®Google Scholar
• Heatherton TF, Kozlowski LT, Frecker RC. The Fagerström test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–1127. doi:10.1111/j.1360-0443.1991.tb01879.x
   PubMedGoogle Scholar
• Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25(4):277–283. doi:10.1016/S0163-8343(03)00043-4
   PubMed Web of Science ®Google Scholar
• Burgos Rincón F, Casan P. Procedimientos de evaluación de la función pulmonar-II [Procedures to assess lung function-II]. In: Sociedad Española de Neumología y Cirugía Torácica, editor. Manual SEPAR de Procedimientos. Barcelona: Publicaciones Permanyer; 2004.
   Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Guía Española de la EPOC (GesEPOC). Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) [Clinical practice guidelines for the diagnosis and therapy of patients with chronic obstructive lung disease (COPD)]. Available from: https://www.archbronconeumol.org/es-pdf-S0300289612700352. Accessed August 21, 2020.
   Google Scholar
• Rieger-Reyes C, García-Tirado FJ, Rubio-Galán FJ, Marín-Trigo JM. Classification of chronic obstructive pulmonary disease severity according to the new global initiative for chronic obstructive lung disease 2011 guidelines: COPD assessment test versus modified medical research council scale. Arch Bronconeumol. 2014;50(4):129–134. doi:10.1016/j.arbr.2014.03.003
   PubMed Web of Science ®Google Scholar
• Llauger Rosselló M, Naberan Toña K. GOLD: estrategia mundial para la enfermedad pulmonar obstructiva crónica (EPOC) [GOLD: global strategy for chronic obstructive lung disease (COPD)]. Atención Primaria. 2003;32(5):306–310. doi:10.1016/S0212-6567(03)79280-4
   PubMedGoogle Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/nejmoa021322
   PubMed Web of Science ®Google Scholar
• Sobradillo V, Miravitlles M, Jiménez CA, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol. 1999;35(4):159–166. doi:10.1016/s0300-2896(15)30272-6
   PubMedGoogle Scholar
• Díez Piña JM, Quílez Ruíz-Rico N, Bilbao-Goyoaga Arenas T. Smoking cessation clinics as an aid for early diagnosis of chronic obstructive pulmonary disease. Arch Bronconeumol. 2015;51(9):470. doi:10.1016/j.arbr.2014.09.019
   PubMed Web of Science ®Google Scholar
• Johnson KM, Sadatsafavi M, Adibi A, et al. Cost effectiveness of case detection strategies for the early detection of COPD. Appl Health Econ Health Policy. 2020. doi:10.1007/s40258-020-00616-2
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Lange P, Vestbo J. Importance of early COPD in young adults for development of clinical COPD: findings from the Copenhagen general population study. Am J Respir Crit Care Med. 2020. doi:10.1164/rccm.202003-0532oc
   Web of Science ®Google Scholar
• Pezzuto A, Lionetto L, Ricci A, Simmaco M, Borro M. Inter-individual variation in CYP2A6 activity and chronic obstructive pulmonary disease in smokers: perspectives for an early predictive marker. Biochim Biophys Acta Mol Basis Dis. 2021;1867(1):165990. doi:10.1016/j.bbadis.2020.165990
   PubMed Web of Science ®Google Scholar
• Pezzuto A, Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: functional analysis. Clin Respir J. 2020;14(1):29–34. doi:10.1111/crj.13096
   PubMed Web of Science ®Google Scholar
• Choi JY, Rhee CK. Diagnosis and treatment of early chronic obstructive lung disease (COPD). J Clin Med. 2020;9(11):3426. doi:10.3390/jcm9113426
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):721–732. doi:10.1016/S0140-6736(09)61290-3
   PubMed Web of Science ®Google Scholar
• Riesco JA, Hidalgo M, Chipayo D, Gómez JJ, Zaragozá F. Profile of cardiovascular disease patients who are diagnosed with COPD in a smoking-cessation unit. Adv Ther. 2020;37(8):3562–3570. doi:10.1007/s12325-020-01403-0
   PubMed Web of Science ®Google Scholar